caprylates has been researched along with rifampin in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | caprylates (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agatonovic-Kustrin, S; Glass, BD; Wisch, MH | 1 |
1 other study(ies) available for caprylates and rifampin
| Article | Year |
|---|---|
Artificial neural networks to optimize formulation components of a fixed-dose combination of rifampicin, isoniazid and pyrazinamide in a microemulsion.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Caprylates; Chemistry, Pharmaceutical; Child; Drug Combinations; Drug Stability; Emulsions; Humans; Isoniazid; Neural Networks, Computer; Polyethylene Glycols; Polysorbates; Pyrazinamide; Rifampin; Solubility; Sorbitol; Triglycerides | 2005 |